Insulin Infusion Pumps Comprehensive Study by Type (Closed Loop Pumps, Open Loop Pumps), Component (Insulin Pump Devices, Infusion Sets, Reservoirs), End User (Hospital, Home Care, Ambulatory Surgery Centers (ACS)) Players and Region - Global Market Outlook to 2027

Insulin Infusion Pumps Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 7.58%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The insulin infusion pump is an insulin-delivering device in the treatment of diabetes. Factors contributing to the growth of the market include increasing prevalence of diabetics, rapid growth in the geriatric population, growing awareness about different insulin delivering devices, and the development of efficient insulin infusion pumps. Moreover, consumer information and professional programs provided by manufacturers of insulin infusion pump propelling the market growth.

AttributesDetails
Study Period2017-2027
Base Year2021
High Growth MarketNorth America
UnitValue (USD Million)
Key Companies ProfiledInsulet Corporation (United States), Medtronic, plc (United States), Roche (Switzerland), Animus Corporation (United States), Tandem Diabetes Care, Inc. (United States), Ypsomed (Switzerland) and Cellnovo Ltd. (United Kingdom)


According to AMA, the market for Insulin Infusion Pumps is expected to register a CAGR of 7.58% during the forecast period to 2027. This growth is primarily driven by The increasing prevalence of diabetes is the major driver attributing to the growth of the insulin infusion pumps market. For instance, according to the International Diabetes Federation (IDF), over 463 million adults in the age group of 20-79 years were living with diabetes in 2019 among which 79% of the patients belong to from low- and middle-income countries. Moreover, this figure is expected to reach 700 million by 2045 which is expected to drive the product demand over the forecasted period..

Globally, a noticeable market trend is evident Growing Awareness about Different Insulin Delivering Devices . The Medical Devices sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Insulet Corporation (United States), Medtronic, plc (United States), Roche (Switzerland), Animus Corporation (United States), Tandem Diabetes Care, Inc. (United States), Ypsomed (Switzerland) and Cellnovo Ltd. (United Kingdom) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
October 2019, Tandem Diabetes Care and Abbott announced today that they aiming to develop and commercialize integrated diabetes solutions that combine Abbott's 1 glucose sensing technology with Tandem's advanced insulin delivery systems to deliver more efficient options for diabetic patients.
October 2019, Novo Nordisk the pharmaceutical company announced that the U.S. Food and Drug Administration (FDA) has expanded the label for insulin aspart injection, Fiasp 100 u/mL to include use in insulin infusion pumps for the enhancement of glycemic control in adults suffering from type 1 or 2 diabetes.

Market Drivers
  • The increasing prevalence of diabetes is the major driver attributing to the growth of the insulin infusion pumps market. For instance, according to the International Diabetes Federation (IDF), over 463 million adults in the age group of 20-79 years were living with diabetes in 2019 among which 79% of the patients belong to from low- and middle-income countries. Moreover, this figure is expected to reach 700 million by 2045 which is expected to drive the product demand over the forecasted period.

Market Trend
  • Growing Awareness about Different Insulin Delivering Devices
  • Increasing Prevalence of Chronic Diseases along with the Rapid Growth in the Geriatric Population

Restraints
  • Lack of Expert Professional for Appropriate Handling of Insulin Infusion Pump
  • Stringent Regulatory Requirements for New Product Launch in Healthcare Market

Opportunities
Emphasizing On Development of Efficient Insulin Infusion Pumps and Rising Demand from the Developing Economies

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Insulin Infusion Pumps Study Sheds Light on
— The Insulin Infusion Pumps Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Insulin Infusion Pumps industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Insulin Infusion Pumps industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Closed Loop Pumps
  • Open Loop Pumps
By Component
  • Insulin Pump Devices
  • Infusion Sets
  • Reservoirs

By End User
  • Hospital
  • Home Care
  • Ambulatory Surgery Centers (ACS)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The increasing prevalence of diabetes is the major driver attributing to the growth of the insulin infusion pumps market. For instance, according to the International Diabetes Federation (IDF), over 463 million adults in the age group of 20-79 years were living with diabetes in 2019 among which 79% of the patients belong to from low- and middle-income countries. Moreover, this figure is expected to reach 700 million by 2045 which is expected to drive the product demand over the forecasted period.
    • 3.3. Market Challenges
      • 3.3.1. Ongoing Research and Development Regarding Oral Insulin
    • 3.4. Market Trends
      • 3.4.1. Growing Awareness about Different Insulin Delivering Devices
      • 3.4.2. Increasing Prevalence of Chronic Diseases along with the Rapid Growth in the Geriatric Population
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Insulin Infusion Pumps, by Type, Component , End User and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Insulin Infusion Pumps (Value)
      • 5.2.1. Global Insulin Infusion Pumps by: Type (Value)
        • 5.2.1.1. Closed Loop Pumps
        • 5.2.1.2. Open Loop Pumps
      • 5.2.2. Global Insulin Infusion Pumps by: End User (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Home Care
        • 5.2.2.3. Ambulatory Surgery Centers (ACS)
      • 5.2.3. Global Insulin Infusion Pumps Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Insulin Infusion Pumps (Volume)
      • 5.3.1. Global Insulin Infusion Pumps by: Type (Volume)
        • 5.3.1.1. Closed Loop Pumps
        • 5.3.1.2. Open Loop Pumps
      • 5.3.2. Global Insulin Infusion Pumps by: End User (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Home Care
        • 5.3.2.3. Ambulatory Surgery Centers (ACS)
      • 5.3.3. Global Insulin Infusion Pumps Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Insulin Infusion Pumps (Price)
      • 5.4.1. Global Insulin Infusion Pumps by: Type (Price)
  • 6. Insulin Infusion Pumps: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Insulet Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic, plc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Roche (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Animus Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Tandem Diabetes Care, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ypsomed (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cellnovo Ltd. (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Insulin Infusion Pumps Sale, by Type, Component , End User and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Insulin Infusion Pumps (Value)
      • 7.2.1. Global Insulin Infusion Pumps by: Type (Value)
        • 7.2.1.1. Closed Loop Pumps
        • 7.2.1.2. Open Loop Pumps
      • 7.2.2. Global Insulin Infusion Pumps by: End User (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Home Care
        • 7.2.2.3. Ambulatory Surgery Centers (ACS)
      • 7.2.3. Global Insulin Infusion Pumps Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Insulin Infusion Pumps (Volume)
      • 7.3.1. Global Insulin Infusion Pumps by: Type (Volume)
        • 7.3.1.1. Closed Loop Pumps
        • 7.3.1.2. Open Loop Pumps
      • 7.3.2. Global Insulin Infusion Pumps by: End User (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Home Care
        • 7.3.2.3. Ambulatory Surgery Centers (ACS)
      • 7.3.3. Global Insulin Infusion Pumps Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Insulin Infusion Pumps (Price)
      • 7.4.1. Global Insulin Infusion Pumps by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Insulin Infusion Pumps: by Type(USD Million)
  • Table 2. Insulin Infusion Pumps Closed Loop Pumps , by Region USD Million (2016-2021)
  • Table 3. Insulin Infusion Pumps Open Loop Pumps , by Region USD Million (2016-2021)
  • Table 4. Insulin Infusion Pumps: by End User(USD Million)
  • Table 5. Insulin Infusion Pumps Hospital , by Region USD Million (2016-2021)
  • Table 6. Insulin Infusion Pumps Home Care , by Region USD Million (2016-2021)
  • Table 7. Insulin Infusion Pumps Ambulatory Surgery Centers (ACS) , by Region USD Million (2016-2021)
  • Table 8. South America Insulin Infusion Pumps, by Country USD Million (2016-2021)
  • Table 9. South America Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 10. South America Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 11. South America Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 12. Brazil Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 13. Brazil Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 14. Brazil Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 15. Argentina Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 16. Argentina Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 17. Argentina Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 18. Rest of South America Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 19. Rest of South America Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 20. Rest of South America Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 21. Asia Pacific Insulin Infusion Pumps, by Country USD Million (2016-2021)
  • Table 22. Asia Pacific Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 23. Asia Pacific Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 24. Asia Pacific Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 25. China Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 26. China Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 27. China Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 28. Japan Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 29. Japan Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 30. Japan Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 31. India Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 32. India Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 33. India Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 34. South Korea Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 35. South Korea Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 36. South Korea Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 37. Taiwan Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 38. Taiwan Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 39. Taiwan Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 40. Australia Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 41. Australia Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 42. Australia Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 43. Rest of Asia-Pacific Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 44. Rest of Asia-Pacific Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 45. Rest of Asia-Pacific Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 46. Europe Insulin Infusion Pumps, by Country USD Million (2016-2021)
  • Table 47. Europe Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 48. Europe Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 49. Europe Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 50. Germany Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 51. Germany Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 52. Germany Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 53. France Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 54. France Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 55. France Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 56. Italy Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 57. Italy Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 58. Italy Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 59. United Kingdom Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 60. United Kingdom Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 61. United Kingdom Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 62. Netherlands Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 63. Netherlands Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 64. Netherlands Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 65. Rest of Europe Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 66. Rest of Europe Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 67. Rest of Europe Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 68. MEA Insulin Infusion Pumps, by Country USD Million (2016-2021)
  • Table 69. MEA Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 70. MEA Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 71. MEA Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 72. Middle East Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 73. Middle East Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 74. Middle East Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 75. Africa Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 76. Africa Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 77. Africa Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 78. North America Insulin Infusion Pumps, by Country USD Million (2016-2021)
  • Table 79. North America Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 80. North America Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 81. North America Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 82. United States Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 83. United States Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 84. United States Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 85. Canada Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 86. Canada Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 87. Canada Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 88. Mexico Insulin Infusion Pumps, by Type USD Million (2016-2021)
  • Table 89. Mexico Insulin Infusion Pumps, by Component USD Million (2016-2021)
  • Table 90. Mexico Insulin Infusion Pumps, by End User USD Million (2016-2021)
  • Table 91. Insulin Infusion Pumps Sales: by Type(Units)
  • Table 92. Insulin Infusion Pumps Sales Closed Loop Pumps , by Region Units (2016-2021)
  • Table 93. Insulin Infusion Pumps Sales Open Loop Pumps , by Region Units (2016-2021)
  • Table 94. Insulin Infusion Pumps Sales: by End User(Units)
  • Table 95. Insulin Infusion Pumps Sales Hospital , by Region Units (2016-2021)
  • Table 96. Insulin Infusion Pumps Sales Home Care , by Region Units (2016-2021)
  • Table 97. Insulin Infusion Pumps Sales Ambulatory Surgery Centers (ACS) , by Region Units (2016-2021)
  • Table 98. South America Insulin Infusion Pumps Sales, by Country Units (2016-2021)
  • Table 99. South America Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 100. South America Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 101. South America Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 102. Brazil Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 103. Brazil Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 104. Brazil Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 105. Argentina Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 106. Argentina Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 107. Argentina Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 108. Rest of South America Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 109. Rest of South America Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 110. Rest of South America Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 111. Asia Pacific Insulin Infusion Pumps Sales, by Country Units (2016-2021)
  • Table 112. Asia Pacific Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 113. Asia Pacific Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 114. Asia Pacific Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 115. China Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 116. China Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 117. China Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 118. Japan Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 119. Japan Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 120. Japan Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 121. India Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 122. India Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 123. India Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 124. South Korea Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 125. South Korea Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 126. South Korea Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 127. Taiwan Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 128. Taiwan Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 129. Taiwan Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 130. Australia Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 131. Australia Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 132. Australia Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 133. Rest of Asia-Pacific Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 134. Rest of Asia-Pacific Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 135. Rest of Asia-Pacific Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 136. Europe Insulin Infusion Pumps Sales, by Country Units (2016-2021)
  • Table 137. Europe Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 138. Europe Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 139. Europe Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 140. Germany Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 141. Germany Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 142. Germany Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 143. France Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 144. France Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 145. France Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 146. Italy Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 147. Italy Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 148. Italy Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 149. United Kingdom Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 150. United Kingdom Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 151. United Kingdom Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 152. Netherlands Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 153. Netherlands Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 154. Netherlands Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 155. Rest of Europe Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 156. Rest of Europe Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 157. Rest of Europe Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 158. MEA Insulin Infusion Pumps Sales, by Country Units (2016-2021)
  • Table 159. MEA Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 160. MEA Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 161. MEA Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 162. Middle East Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 163. Middle East Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 164. Middle East Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 165. Africa Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 166. Africa Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 167. Africa Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 168. North America Insulin Infusion Pumps Sales, by Country Units (2016-2021)
  • Table 169. North America Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 170. North America Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 171. North America Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 172. United States Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 173. United States Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 174. United States Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 175. Canada Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 176. Canada Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 177. Canada Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 178. Mexico Insulin Infusion Pumps Sales, by Type Units (2016-2021)
  • Table 179. Mexico Insulin Infusion Pumps Sales, by Component Units (2016-2021)
  • Table 180. Mexico Insulin Infusion Pumps Sales, by End User Units (2016-2021)
  • Table 181. Insulin Infusion Pumps: by Type(USD/Units)
  • Table 182. Company Basic Information, Sales Area and Its Competitors
  • Table 183. Company Basic Information, Sales Area and Its Competitors
  • Table 184. Company Basic Information, Sales Area and Its Competitors
  • Table 185. Company Basic Information, Sales Area and Its Competitors
  • Table 186. Company Basic Information, Sales Area and Its Competitors
  • Table 187. Company Basic Information, Sales Area and Its Competitors
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Insulin Infusion Pumps: by Type(USD Million)
  • Table 190. Insulin Infusion Pumps Closed Loop Pumps , by Region USD Million (2022-2027)
  • Table 191. Insulin Infusion Pumps Open Loop Pumps , by Region USD Million (2022-2027)
  • Table 192. Insulin Infusion Pumps: by End User(USD Million)
  • Table 193. Insulin Infusion Pumps Hospital , by Region USD Million (2022-2027)
  • Table 194. Insulin Infusion Pumps Home Care , by Region USD Million (2022-2027)
  • Table 195. Insulin Infusion Pumps Ambulatory Surgery Centers (ACS) , by Region USD Million (2022-2027)
  • Table 196. South America Insulin Infusion Pumps, by Country USD Million (2022-2027)
  • Table 197. South America Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 198. South America Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 199. South America Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 200. Brazil Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 201. Brazil Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 202. Brazil Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 203. Argentina Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 204. Argentina Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 205. Argentina Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 206. Rest of South America Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 207. Rest of South America Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 208. Rest of South America Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 209. Asia Pacific Insulin Infusion Pumps, by Country USD Million (2022-2027)
  • Table 210. Asia Pacific Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 211. Asia Pacific Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 212. Asia Pacific Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 213. China Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 214. China Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 215. China Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 216. Japan Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 217. Japan Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 218. Japan Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 219. India Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 220. India Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 221. India Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 222. South Korea Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 223. South Korea Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 224. South Korea Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 225. Taiwan Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 226. Taiwan Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 227. Taiwan Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 228. Australia Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 229. Australia Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 230. Australia Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 231. Rest of Asia-Pacific Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 232. Rest of Asia-Pacific Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 233. Rest of Asia-Pacific Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 234. Europe Insulin Infusion Pumps, by Country USD Million (2022-2027)
  • Table 235. Europe Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 236. Europe Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 237. Europe Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 238. Germany Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 239. Germany Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 240. Germany Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 241. France Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 242. France Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 243. France Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 244. Italy Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 245. Italy Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 246. Italy Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 247. United Kingdom Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 248. United Kingdom Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 249. United Kingdom Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 250. Netherlands Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 251. Netherlands Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 252. Netherlands Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 253. Rest of Europe Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 254. Rest of Europe Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 255. Rest of Europe Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 256. MEA Insulin Infusion Pumps, by Country USD Million (2022-2027)
  • Table 257. MEA Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 258. MEA Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 259. MEA Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 260. Middle East Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 261. Middle East Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 262. Middle East Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 263. Africa Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 264. Africa Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 265. Africa Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 266. North America Insulin Infusion Pumps, by Country USD Million (2022-2027)
  • Table 267. North America Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 268. North America Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 269. North America Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 270. United States Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 271. United States Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 272. United States Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 273. Canada Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 274. Canada Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 275. Canada Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 276. Mexico Insulin Infusion Pumps, by Type USD Million (2022-2027)
  • Table 277. Mexico Insulin Infusion Pumps, by Component USD Million (2022-2027)
  • Table 278. Mexico Insulin Infusion Pumps, by End User USD Million (2022-2027)
  • Table 279. Insulin Infusion Pumps Sales: by Type(Units)
  • Table 280. Insulin Infusion Pumps Sales Closed Loop Pumps , by Region Units (2022-2027)
  • Table 281. Insulin Infusion Pumps Sales Open Loop Pumps , by Region Units (2022-2027)
  • Table 282. Insulin Infusion Pumps Sales: by End User(Units)
  • Table 283. Insulin Infusion Pumps Sales Hospital , by Region Units (2022-2027)
  • Table 284. Insulin Infusion Pumps Sales Home Care , by Region Units (2022-2027)
  • Table 285. Insulin Infusion Pumps Sales Ambulatory Surgery Centers (ACS) , by Region Units (2022-2027)
  • Table 286. South America Insulin Infusion Pumps Sales, by Country Units (2022-2027)
  • Table 287. South America Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 288. South America Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 289. South America Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 290. Brazil Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 291. Brazil Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 292. Brazil Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 293. Argentina Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 294. Argentina Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 295. Argentina Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 296. Rest of South America Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 297. Rest of South America Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 298. Rest of South America Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 299. Asia Pacific Insulin Infusion Pumps Sales, by Country Units (2022-2027)
  • Table 300. Asia Pacific Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 301. Asia Pacific Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 302. Asia Pacific Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 303. China Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 304. China Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 305. China Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 306. Japan Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 307. Japan Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 308. Japan Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 309. India Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 310. India Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 311. India Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 312. South Korea Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 313. South Korea Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 314. South Korea Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 315. Taiwan Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 316. Taiwan Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 317. Taiwan Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 318. Australia Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 319. Australia Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 320. Australia Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 321. Rest of Asia-Pacific Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 322. Rest of Asia-Pacific Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 323. Rest of Asia-Pacific Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 324. Europe Insulin Infusion Pumps Sales, by Country Units (2022-2027)
  • Table 325. Europe Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 326. Europe Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 327. Europe Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 328. Germany Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 329. Germany Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 330. Germany Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 331. France Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 332. France Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 333. France Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 334. Italy Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 335. Italy Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 336. Italy Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 337. United Kingdom Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 338. United Kingdom Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 339. United Kingdom Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 340. Netherlands Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 341. Netherlands Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 342. Netherlands Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 343. Rest of Europe Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 344. Rest of Europe Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 345. Rest of Europe Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 346. MEA Insulin Infusion Pumps Sales, by Country Units (2022-2027)
  • Table 347. MEA Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 348. MEA Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 349. MEA Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 350. Middle East Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 351. Middle East Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 352. Middle East Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 353. Africa Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 354. Africa Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 355. Africa Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 356. North America Insulin Infusion Pumps Sales, by Country Units (2022-2027)
  • Table 357. North America Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 358. North America Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 359. North America Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 360. United States Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 361. United States Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 362. United States Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 363. Canada Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 364. Canada Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 365. Canada Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 366. Mexico Insulin Infusion Pumps Sales, by Type Units (2022-2027)
  • Table 367. Mexico Insulin Infusion Pumps Sales, by Component Units (2022-2027)
  • Table 368. Mexico Insulin Infusion Pumps Sales, by End User Units (2022-2027)
  • Table 369. Insulin Infusion Pumps: by Type(USD/Units)
  • Table 370. Research Programs/Design for This Report
  • Table 371. Key Data Information from Secondary Sources
  • Table 372. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Insulin Infusion Pumps: by Type USD Million (2016-2021)
  • Figure 5. Global Insulin Infusion Pumps: by End User USD Million (2016-2021)
  • Figure 6. South America Insulin Infusion Pumps Share (%), by Country
  • Figure 7. Asia Pacific Insulin Infusion Pumps Share (%), by Country
  • Figure 8. Europe Insulin Infusion Pumps Share (%), by Country
  • Figure 9. MEA Insulin Infusion Pumps Share (%), by Country
  • Figure 10. North America Insulin Infusion Pumps Share (%), by Country
  • Figure 11. Global Insulin Infusion Pumps: by Type Units (2016-2021)
  • Figure 12. Global Insulin Infusion Pumps: by End User Units (2016-2021)
  • Figure 13. South America Insulin Infusion Pumps Share (%), by Country
  • Figure 14. Asia Pacific Insulin Infusion Pumps Share (%), by Country
  • Figure 15. Europe Insulin Infusion Pumps Share (%), by Country
  • Figure 16. MEA Insulin Infusion Pumps Share (%), by Country
  • Figure 17. North America Insulin Infusion Pumps Share (%), by Country
  • Figure 18. Global Insulin Infusion Pumps: by Type USD/Units (2016-2021)
  • Figure 19. Global Insulin Infusion Pumps share by Players 2021 (%)
  • Figure 20. Global Insulin Infusion Pumps share by Players (Top 3) 2021(%)
  • Figure 21. BCG Matrix for key Companies
  • Figure 22. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Insulet Corporation (United States) Revenue: by Geography 2021
  • Figure 24. Medtronic, plc (United States) Revenue, Net Income and Gross profit
  • Figure 25. Medtronic, plc (United States) Revenue: by Geography 2021
  • Figure 26. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. Roche (Switzerland) Revenue: by Geography 2021
  • Figure 28. Animus Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Animus Corporation (United States) Revenue: by Geography 2021
  • Figure 30. Tandem Diabetes Care, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Tandem Diabetes Care, Inc. (United States) Revenue: by Geography 2021
  • Figure 32. Ypsomed (Switzerland) Revenue, Net Income and Gross profit
  • Figure 33. Ypsomed (Switzerland) Revenue: by Geography 2021
  • Figure 34. Cellnovo Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Cellnovo Ltd. (United Kingdom) Revenue: by Geography 2021
  • Figure 36. Global Insulin Infusion Pumps: by Type USD Million (2022-2027)
  • Figure 37. Global Insulin Infusion Pumps: by End User USD Million (2022-2027)
  • Figure 38. South America Insulin Infusion Pumps Share (%), by Country
  • Figure 39. Asia Pacific Insulin Infusion Pumps Share (%), by Country
  • Figure 40. Europe Insulin Infusion Pumps Share (%), by Country
  • Figure 41. MEA Insulin Infusion Pumps Share (%), by Country
  • Figure 42. North America Insulin Infusion Pumps Share (%), by Country
  • Figure 43. Global Insulin Infusion Pumps: by Type Units (2022-2027)
  • Figure 44. Global Insulin Infusion Pumps: by End User Units (2022-2027)
  • Figure 45. South America Insulin Infusion Pumps Share (%), by Country
  • Figure 46. Asia Pacific Insulin Infusion Pumps Share (%), by Country
  • Figure 47. Europe Insulin Infusion Pumps Share (%), by Country
  • Figure 48. MEA Insulin Infusion Pumps Share (%), by Country
  • Figure 49. North America Insulin Infusion Pumps Share (%), by Country
  • Figure 50. Global Insulin Infusion Pumps: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Insulet Corporation (United States)
  • Medtronic, plc (United States)
  • Roche (Switzerland)
  • Animus Corporation (United States)
  • Tandem Diabetes Care, Inc. (United States)
  • Ypsomed (Switzerland)
  • Cellnovo Ltd. (United Kingdom)
Select User Access Type

Key Highlights of Report


May 2022 128 Pages 79 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Insulin Infusion Pumps market are Insulet Corporation (United States), Medtronic, plc (United States), Roche (Switzerland), Animus Corporation (United States), Tandem Diabetes Care, Inc. (United States), Ypsomed (Switzerland) and Cellnovo Ltd. (United Kingdom), to name a few.
North America is dominating the Insulin Infusion Pumps Market.
"Ongoing Research and Development Regarding Oral Insulin" is seen as one of major challenge by many Industry Players of Insulin Infusion Pumps Market
The Insulin Infusion Pumps market is expected to see a CAGR of 7.58% during projected year 2021 to 2027.

Know More About Global Insulin Infusion Pumps Report?